create ppt detailed presentation

Created using ChatSlide

This study evaluates the clinical rationale and architecture of a multicenter, open-label randomized trial focusing on MMA embolization to reduce recurrence rates. The primary endpoint is the six-month recurrence rate, showing 14.8% with MMA embolization compared to 21.0% with standard care. Despite the findings indicating no significant reduction in recurrence, they align with previous trials using different embolic agents, prompting further investigation into agent selection and...